×
About 455 results

ALLMedicine™ Gastrinoma Center

Research & Reviews  143 results

Recurrence after surgical resection of nonmetastatic sporadic gastrinoma: Which prognos...
https://doi.org/10.1016/j.surg.2022.12.030
Surgery Robin L, Sauvanet A et. al.

Feb 14th, 2023 - The only curative treatment of gastrinoma is complete resection, but its surgical management remains controversial and prognostic factors of sporadic nonmetastatic gastrinoma are poorly known. This was a retrospective study including all patients ...

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
https://clinicaltrials.gov/ct2/show/NCT05673031

Jan 5th, 2023 - The purpose of the current study will be to evaluate the usefulness of 68Ga-HA-DOTATATE compared to current standard anatomical imaging including CT, MRI, 111 In-pentetreotide Scans, 18F-FDG PET/CT, as available. Specifically, we aim to assess the...

Glucagonoma
https://emedicine.medscape.com/article/118899-overview

Dec 16th, 2022 - Practice Essentials A glucagonoma is a rare neuroendocrine tumor that originates almost exclusively in the pancreas and probably accounts for 1% of all neuroendocrine tumors. Malignant glucagonomas are islet cell pancreatic tumors that are discove...

Glucagonoma
http://emedicine.medscape.com/article/118899-overview

Dec 16th, 2022 - Practice Essentials A glucagonoma is a rare neuroendocrine tumor that originates almost exclusively in the pancreas and probably accounts for 1% of all neuroendocrine tumors. Malignant glucagonomas are islet cell pancreatic tumors that are discove...

Glucagonoma
https://emedicine.medscape.com/article/118899-print

Dec 16th, 2022 - Practice Essentials A glucagonoma is a rare neuroendocrine tumor that originates almost exclusively in the pancreas and probably accounts for 1% of all neuroendocrine tumors. Malignant glucagonomas are islet cell pancreatic tumors that are discove...

see more →

Drugs  16 results see all →

Clinicaltrials.gov  4 results

68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
https://clinicaltrials.gov/ct2/show/NCT05673031

Jan 5th, 2023 - The purpose of the current study will be to evaluate the usefulness of 68Ga-HA-DOTATATE compared to current standard anatomical imaging including CT, MRI, 111 In-pentetreotide Scans, 18F-FDG PET/CT, as available. Specifically, we aim to assess the...

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer
https://clinicaltrials.gov/ct2/show/NCT00001228

Jul 2nd, 2017 - Heretofore morbidity and mortality in Zollinger-Ellison syndrome were caused by severe ulcer disease. The advent of specific drugs to cure ulcer disease now extends life until metastases from the non-B-islet cell tumor or other events cause death....

Treatment of Zollinger-Ellison Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001241

Jul 2nd, 2017 - This protocol describes the use of histamine H2-receptor antagonists to control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. It details which patients will be considered for treatment with these agents, the pretreatment...

Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT02345239

Jan 26th, 2015 - Diabetes mellitus is a complex chronic disease associated with an absolute insulin deficiency in type1 diabetes and a progressive deterioration of b-cell function in type 2 diabetes. The pathophysiology of type 2 diabetes includes not only the cla...

see more →

News  14 results

Neuroendocrine Tumors Clinical Practice Guidelines (NCCN, 2021)
https://www.medscape.com/viewarticle/959868

Sep 30th, 2021 - Updated clinical guidelines on the diagnosis and management of neuroendocrine and adrenal tumors were released in 2021 by the National Comprehensive Cancer Network (NCCN). The new version of the guidelines, published in the Journal of the National...

Using Somatostatin Analogs in pNETs
https://www.onclive.com/view/using-somatostatin-analogs-in-pnets

Apr 2nd, 2021 - Somatostatin analogs have historically been used for symptom control in patients with pancreatic neuroendocrine tumors (pNETs); however, these agents are now being considered for their antitumor properties. Functional patients with pNETs typically...

Genomic Diversity Clouds Outlook for Neuroendocrine Tumors
https://www.onclive.com/view/genomic-diversity-clouds-outlook-for-neuroendocrine-tumors

Dec 5th, 2020 - Despite a spate of therapeutic advances in recent years, neuroendocrine (NET) tumors remain a poorly investigated collection of cancers whose rarity has limited clinical trial enrollment. Now, genome sequencing studies are providing clues for ther...

April 2019 - Question 2
https://www.mdedge.com/gihepnews/article/197788/april-2019-question-2

Mar 29th, 2019 - Critique: Factors raising suspicion for Zollinger-Ellison syndrome include recurrent peptic ulcer disease, multiple ulcers, post-bulbar ulcer, non-H. pylori/non-NSAID-related duodenal ulcer, diarrhea, erosive esophagitis, and family or personal hi.

DDSEP® 8 Quick Quiz - February 2018 Question 1
https://www.mdedge.com/gihepnews/article/157422/ddsepr-8-quick-quiz-february-2018-question-1

Feb 1st, 2018 - Answer: B Rationale Hypergastrinemia is normally a physiologic response to hypochlorhydria. When hypergastrinemia occurs in the setting of acidic gastric pH, it is considered inappropriate.

see more →

Patient Education  5 results see all →